Cargando…
Health economic evidence for the use of molecular biomarker tests in hematological malignancies: A systematic review
OBJECTIVES: Molecular biomarker tests can inform the clinical management of genomic heterogeneous hematological malignancies, yet their availability in routine care largely depends on the supporting health economic evidence. This study aims to systematically review the economic evidence for recent m...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310724/ https://www.ncbi.nlm.nih.gov/pubmed/35158410 http://dx.doi.org/10.1111/ejh.13755 |